Radiotherapy for Children with Head-and-Neck Rhabdomyosarcoma
Author Information
Author(s): Stephanie E Combs, Wolfgang Behnisch, Andreas E Kulozik, Peter E Huber, Jürgen Debus, Daniela Schulz-Ertner
Primary Institution: University of Heidelberg
Hypothesis
The study evaluates the efficacy and toxicity of FSRT and IMRT in children with head and neck rhabdomyosarcoma.
Conclusion
IMRT and FSRT lead to excellent outcomes in children with head-and-neck RMS with a low incidence of treatment-related side effects.
Supporting Evidence
- The 3- and 5-year survival rate was 94%.
- The 3- and 5-year local control rate after RT was 89%.
- Radiotherapy was well tolerated in all children.
Takeaway
Doctors used special types of radiation therapy to help kids with a type of cancer in their head and neck, and it worked really well with few side effects.
Methodology
The study treated 19 children with FSRT or IMRT as part of multimodal therapy and collected data retrospectively.
Limitations
The small sample size may limit the generalizability of the findings.
Participant Demographics
Median age was 5 years, with a male to female ratio of 1.4:1.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website